<p>作者：Tomi Kilgore</p>
<p>据报道，特朗普正在考虑签署一项行政命令，将大麻降级为第三类药物，这可能为银行服务打开大门。</p>
<p>在有关特朗普政府可能将大麻重新分类为一种远不如现在危险的药物的报道后，Tilray 的股票以及其他大麻公司的股票飙升，给投资者带来了希望。</p>
<p>周五，Tilray Brands 的股票大幅上涨，市场对大麻终于有望被重新分类为低级别药物的希望不断上升，这可能为进一步合法化和银行服务打开大门。</p>
<p>《华盛顿邮报》周四晚间报道，特朗普总统正在推动将大麻重新分类为第三类药物，与一些处方药如含可待因的泰诺或类固醇并列。目前，大麻被分类为第一类药物，与海洛因和迷幻药 LSD 同级。</p>
<p>CNBC 周五报道，特朗普可能在周一签署行政命令，将大麻重新分类。</p>
<p>来自档案（2024 年 9 月）：在共和党候选人特朗普支持将大麻转移到限制较少的类别后，大麻股票上涨。</p>
<p>这对 Tilray（TLRY）以及所有合法的大麻生产商和销售商来说都是一个好消息，原因有很多。但最重要的可能是，这可能会促使大型银行进入大麻业务，而他们一直避免这样做，因为大麻在联邦层面被归类为非法，依据是《管制物质法》。</p>
<p>周五，Tilray 的股票上涨了 44.1%。交易量激增至超过 8000 万股，而过去 30 天的日均交易量约为 510 万股。</p>
<p>在大麻行业的其他公司中，加拿大大麻公司 Canopy Growth Corp.（CGC）（CA:WEED）的股票上涨了 54%，而 Cronos Group 的股票上涨了 14.7%。AdvisorShares Pure U.S. Cannabis ETF MSOS 飙升 54.3%，创下 13 个月来的新高。</p>
<p>缺乏银行服务使得合法的大麻业务难以运营，因为缺乏资金以及处理大量现金所带来的风险。</p>
<p>尽管旨在保护银行在大麻合法的州内开展业务不受联邦限制的《安全与公平执法监管法案》（SAFER）已在众议院多次获得通过，但在参议院尚未获得投票。</p>
<p>特朗普的行政命令可能会改变这一切。</p>
<p>&#34;从更大的角度来看，这将是几十年来最显著的大麻改革，并为我们认为的多个额外催化剂奠定基础，包括更多州合法化大麻、SAFER 银行法案的通过，&#34;最终使接触大麻的公司能够将其股票上市到主要的美国证券交易所，Alliance Global Partners 的分析师 Aaron Grey 在给客户的报告中写道。</p>
<p>他说，这也可能导致传统消费品公司进行战略投资。</p>
<p>请记住，《华盛顿邮报》的报道指出，白宫表示尚未做出任何决定，而大麻投资者之前曾遭受损失。</p>
<p>例如，Tilray 周五的股票上涨是自 9 月 29 日以来最大的一次。当天上涨了创纪录的 60.9%，收于 18.50 美元，此前特朗普在他的社交媒体平台 Truth Social 上分享了一段视频，宣传了大麻植物中的一种化合物——大麻二酚在老年人护理中的好处。</p>
<p>周五，即使在大幅上涨后，Tilray 的股票仍比 9 月 29 日收盘时低 34.3%。</p>
<p>来自档案（2025 年 2 月）：Trulieve、Curaleaf 和 Green Thumb 推出基于大麻的 THC 饮料，因大麻改革停滞不前。</p>
<p>-Tomi Kilgore</p>
<p>此内容由 MarketWatch 创作，MarketWatch 由道琼斯公司运营。MarketWatch 与道琼斯新闻通讯和《华尔街日报》独立出版。</p>
<p>（完）道琼斯新闻通讯</p>
<p>12-12-25 1722ET</p>

CRON

TLRY

<p>Tilray 的股票上涨了 44.1%，因为有报道称特朗普总统可能会将大麻重新分类为第三类药物，从而放宽银行限制，并可能导致进一步的合法化。这一重新分类可能允许大型银行与大麻企业进行交易，从而推动该行业的发展。其他大麻股票，如 Canopy Growth 和 Cronos Group，也出现了显著的涨幅。然而，白宫尚未确认任何决定，过去投资者的乐观情绪有时也显得过于仓促</p>

<p>By Tomi Kilgore</p>
<div class="lb-trans"><p>作者：Tomi Kilgore</p>
</div><p>Trump is reportedly mulling an executive order to downgrade marijuana to a Schedule III drug, which could open the door to banking services</p>
<div class="lb-trans"><p>据报道，特朗普正在考虑签署一项行政命令，将大麻降级为第三类药物，这可能为银行服务打开大门。</p>
</div><p>Tilray's stock, and shares of other cannabis companies, soared after reports gave investors hope that the Trump administration would move to have marijuana reclassified as a much less dangerous drug than it is now.</p>
<div class="lb-trans"><p>在有关特朗普政府可能将大麻重新分类为一种远不如现在危险的药物的报道后，Tilray 的股票以及其他大麻公司的股票飙升，给投资者带来了希望。</p>
</div><p>Shares of Tilray Brands rocketed Friday amid rising hope that cannabis is finally on the doorstep of being rescheduled as a lower-class drug, which could open doors for further legalization and banking services.</p>
<div class="lb-trans"><p>周五，Tilray Brands 的股票大幅上涨，市场对大麻终于有望被重新分类为低级别药物的希望不断上升，这可能为进一步合法化和银行服务打开大门。</p>
</div><p>The Washington Post reported late Thursday that President Donald Trump was pushing to reclassify marijuana as a Schedule III drug alongside some prescription drugs like Tylenol with codeine or anabolic steroids. It is currently classified as a Schedule I drug, on par with heroin and lysergic acid diethylamide, or LSD.</p>
<div class="lb-trans"><p>《华盛顿邮报》周四晚间报道，特朗普总统正在推动将大麻重新分类为第三类药物，与一些处方药如含可待因的泰诺或类固醇并列。目前，大麻被分类为第一类药物，与海洛因和迷幻药 LSD 同级。</p>
</div><p>CNBC reported Friday that Trump could sign an executive order to reschedule marijuana as soon as Monday.</p>
<div class="lb-trans"><p>CNBC 周五报道，特朗普可能在周一签署行政命令，将大麻重新分类。</p>
</div><p>From the archives (September 2024): Cannabis stocks rally after Republican candidate Trump supports moving drug to less restrictive category</p>
<div class="lb-trans"><p>来自档案（2024 年 9 月）：在共和党候选人特朗普支持将大麻转移到限制较少的类别后，大麻股票上涨。</p>
</div><p>That would be a boon for Tilray (TLRY), and for all legal cannabis producers and sellers, for a few reasons. But probably the most important is that it would likely lead to larger banks to get into the weed businesses, something they've avoided because cannabis was federally classified as illegal under the Controlled Substance Act.</p>
<div class="lb-trans"><p>这对 Tilray（TLRY）以及所有合法的大麻生产商和销售商来说都是一个好消息，原因有很多。但最重要的可能是，这可能会促使大型银行进入大麻业务，而他们一直避免这样做，因为大麻在联邦层面被归类为非法，依据是《管制物质法》。</p>
</div><p>Tilray's stock soared 44.1% on Friday. Trading volume ballooned to well above 80 million shares, compared with the full-day average over the past 30 days of about 5.1 million shares.</p>
<div class="lb-trans"><p>周五，Tilray 的股票上涨了 44.1%。交易量激增至超过 8000 万股，而过去 30 天的日均交易量约为 510 万股。</p>
</div><p>Among others in the weed business, shares of Canopy Growth Corp. (CGC) (CA:WEED) shot up 54%, and Cronos Group's stock ran up 14.7%. The AdvisorShares Pure U.S. Cannabis ETF MSOS skyrocketed 54.3% to a 13-month high.</p>
<div class="lb-trans"><p>在大麻行业的其他公司中，加拿大大麻公司 Canopy Growth Corp.（CGC）（CA:WEED）的股票上涨了 54%，而 Cronos Group 的股票上涨了 14.7%。AdvisorShares Pure U.S. Cannabis ETF MSOS 飙升 54.3%，创下 13 个月来的新高。</p>
</div><p>The lack of banking options has made it difficult to run a legal cannabis business given the lack of funding and the dangers associated with dealing in piles of cash.</p>
<div class="lb-trans"><p>缺乏银行服务使得合法的大麻业务难以运营，因为缺乏资金以及处理大量现金所带来的风险。</p>
</div><p>And while the Secure and Fair Enforcement Regulation, or SAFER, banking act, aimed at protecting banks from federal restrictions when doing business in a state where cannabis was legal, has been approved by the House of Representatives multiple times, it has yet to get a vote in the Senate.</p>
<div class="lb-trans"><p>尽管旨在保护银行在大麻合法的州内开展业务不受联邦限制的《安全与公平执法监管法案》（SAFER）已在众议院多次获得通过，但在参议院尚未获得投票。</p>
</div><p>An executive order from Trump could change all that.</p>
<div class="lb-trans"><p>特朗普的行政命令可能会改变这一切。</p>
</div><p>&#34;Bigger picture, this would be the most notable cannabis reform in decades and set the stage for a number of additional catalysts in our view, including additional states legalizing cannabis, SAFER banking being passed,&#34; and ultimately having plant-touching cannabis companies move the listing of their stocks to major U.S. stock exchanges, Alliance Global Partners analyst Aaron Grey wrote in a note to clients.</p>
<div class="lb-trans"><p>&#34;从更大的角度来看，这将是几十年来最显著的大麻改革，并为我们认为的多个额外催化剂奠定基础，包括更多州合法化大麻、SAFER 银行法案的通过，&#34;最终使接触大麻的公司能够将其股票上市到主要的美国证券交易所，Alliance Global Partners 的分析师 Aaron Grey 在给客户的报告中写道。</p>
</div><p>He said it could also lead to strategic investments from companies in traditional consumer-facing businesses.</p>
<div class="lb-trans"><p>他说，这也可能导致传统消费品公司进行战略投资。</p>
</div><p>Keep in mind that the Washington Post story noted that the White House said no decision has yet been made, and that cannabis investors have been burned before.</p>
<div class="lb-trans"><p>请记住，《华盛顿邮报》的报道指出，白宫表示尚未做出任何决定，而大麻投资者之前曾遭受损失。</p>
</div><p>For example, Tilray's stock rally Friday was the biggest since Sept. 29. It had gained a record 60.9% that day, to close at $18.50, after Trump shared a video on his social-media platform Truth Social, which touted the benefits of cannabidiol - a compound from the cannabis plant - in the care of seniors.</p>
<div class="lb-trans"><p>例如，Tilray 周五的股票上涨是自 9 月 29 日以来最大的一次。当天上涨了创纪录的 60.9%，收于 18.50 美元，此前特朗普在他的社交媒体平台 Truth Social 上分享了一段视频，宣传了大麻植物中的一种化合物——大麻二酚在老年人护理中的好处。</p>
</div><p>On Friday, even after the big run-up, Tilray's stock ended the trading week 34.3% below where it closed on Sept. 29.</p>
<div class="lb-trans"><p>周五，即使在大幅上涨后，Tilray 的股票仍比 9 月 29 日收盘时低 34.3%。</p>
</div><p>From the archives (February 2025): Trulieve, Curaleaf and Green Thumb launch hemp-based THC drinks as cannabis reforms stall</p>
<div class="lb-trans"><p>来自档案（2025 年 2 月）：Trulieve、Curaleaf 和 Green Thumb 推出基于大麻的 THC 饮料，因大麻改革停滞不前。</p>
</div><p>-Tomi Kilgore</p>
<div class="lb-trans"><p>-Tomi Kilgore</p>
</div><p>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</p>
<div class="lb-trans"><p>此内容由 MarketWatch 创作，MarketWatch 由道琼斯公司运营。MarketWatch 与道琼斯新闻通讯和《华尔街日报》独立出版。</p>
</div><p>(END) Dow Jones Newswires</p>
<div class="lb-trans"><p>（完）道琼斯新闻通讯</p>
</div><p>12-12-25 1722ET</p>
<div class="lb-trans"><p>12-12-25 1722ET</p>
</div>

Tilray's stock takes off on hope that cannabis will soon be seen as more like steroids than heroin

Tilray 的股票因市场希望大麻将很快被视为更类似于类固醇而非海洛因而大幅上涨